Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis

Abstract Introduction Glecaprevir/pibrentasvir (G/P) is globally approved for the treatment of chronic hepatitis C virus (HCV) infection and for acute HCV infection in the USA. The efficacy and safety of G/P has been clinically demonstrated in participants with chronic HCV. We used clinical trial da...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Curtis Cooper, Shweta A. Raina, Lisa Johnson, Jordan J. Feld, Ashley Brown, Anthony Martinez, Brian Conway, Stuart C. Gordon, Tarik Asselah, Liz Uribe, Moming Li, Alexandru Iacob, John Marcinak, Dimitri Semizarov, Stanislas Pol
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2026-04-01
Sarja:	Infectious Diseases and Therapy
Aiheet:	Chronic HCV infection Glecaprevir Pibrentasvir Comorbidity Concomitant medication Polypharmacy
Linkit:	https://doi.org/10.1007/s40121-026-01339-y
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!